RA
Rakesh Agarwal
About Rakesh Agarwal
Data last updated:
Rakesh Agarwal is a Director at Aditya Narasimha Pharmacy Private Limited (since 2025), Director at Baba Puranmal Chit Fund Private Limited (since 2009) and Designated Partner at Raksan Traders Llp (since 2025), and holds 1 more current directorship. The companies operate in Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹59.65 Cr; the largest is Aditya Narasimha Pharmacy Private Limited at ₹54.73 Cr (FY 2024). Earlier, Rakesh Agarwal was a Director at Dream Huts Private Limited (from 2011).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Apr 2025 | 2016 | ₹54.73 Cr (FY 2024) | Active | |
| Director | 26 May 2009 | 2009 | ₹4.92 Cr (FY 2025) | Active | |
| Designated Partner | 15 Apr 2025 | 2025 | Active | ||
| Designated Partner | 04 Jul 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Oct 2011 | 2011 | ₹1.2 Lakh (FY 2022) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rakesh Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jayesh Agarwal | 09395910 | Aditya Narasimha Pharmacy Private Limited | Director |
| Kush Gupta | 10146378 | Aditya Narasimha Pharmacy Private Limited | Director |
| Leela Krishna Penumethsa | 07619055 | Aditya Narasimha Pharmacy Private Limited | Managing Director |
| Rajesh Kumar Gupta | 10215051 | Aditya Narasimha Pharmacy Private Limited | Director |
| Seema Agarwal | 10696346 | Aditya Narasimha Pharmacy Private Limited | Director |
| Anita Agarwal | 02160793 | Baba Puranmal Chit Fund Private Limited , Dream Huts Llp | Director |
| Nikhil Agarwal | 02617428 | Baba Puranmal Chit Fund Private Limited , Dream Huts Llp | Director |
| Santosh Agarwal | 02162176 | Baba Puranmal Chit Fund Private Limited , Raksan Traders Llp and 1 more | Director |
| Shikha Agarwal | 09832510 | Baba Puranmal Chit Fund Private Limited | Director |
| Vibha Agarwal | 09834711 | Baba Puranmal Chit Fund Private Limited | Director |
| Vishwas Agarwal | 06487525 | Baba Puranmal Chit Fund Private Limited , Dream Huts Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakesh Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakesh Agarwal
Rakesh Agarwal currently holds 4 directorships: Aditya Narasimha Pharmacy Private Limited (Director, since 21 Apr 2025, revenue ₹54.73 Cr (FY 2024)); Baba Puranmal Chit Fund Private Limited (Director, since 26 May 2009, revenue ₹4.92 Cr (FY 2025)); Raksan Traders Llp (Designated Partner, since 15 Apr 2025); Dream Huts Llp (Designated Partner, since 04 Jul 2024).
Rakesh Agarwal was first appointed on 26 May 2009 as Director at Baba Puranmal Chit Fund Private Limited. The most recent appointment on record is 21 Apr 2025 at Aditya Narasimha Pharmacy Private Limited.
The 2 current companies of Rakesh Agarwal that report revenue have a combined latest revenue of ₹59.65 Cr: Aditya Narasimha Pharmacy Private Limited ₹54.73 Cr (FY 2024); Baba Puranmal Chit Fund Private Limited ₹4.92 Cr (FY 2025).
Rakesh Agarwal held 1 earlier board appointment: Dream Huts Private Limited (Director, from 25 Oct 2011).
The current boards of Rakesh Agarwal's companies include Jayesh Agarwal (Aditya Narasimha Pharmacy Private Limited), Kush Gupta (Aditya Narasimha Pharmacy Private Limited), Leela Krishna Penumethsa (Aditya Narasimha Pharmacy Private Limited), Rajesh Kumar Gupta (Aditya Narasimha Pharmacy Private Limited), Seema Agarwal (Aditya Narasimha Pharmacy Private Limited), Anita Agarwal (Baba Puranmal Chit Fund Private Limited), among others.